Locations:
November 29, 2018/Pulmonary/Lung Transplant

Airway Complications After Lung Transplantation

Taking steps toward standardizing prevention and management

By Marie Budev, DO, MPH, and Michael Machuzak, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Early in the history of lung transplantation, airway complications were recognized as a major contributor to morbidity and mortality. Improvements in lung preservation, surgical techniques and perioperative management have led to a decrease in the incidence of airway complications, but they continue to adversely impact outcomes following transplantation. The incidence of airway complications has been reported to be in the range of 2 to 18 percent, with this marked variability attributed to lack of standardized definitions for diagnosis.

Airway complications, in the form of dehiscence, stenosis or malacia, most commonly involve the bronchial anastomosis, but the latter two complications also can involve the bronchial tree distal to the anastomosis. While initially encountered in the early post-transplant period, airway complications can persist as a chronic, recurrent problem throughout the post-transplant course.

Recently, we were invited by the International Society for Heart and Lung Transplantation to join the Airway Complications Workgroup, comprised of experts in lung transplantation and interventional pulmonology from around the world. The Airway Complications Workgroup developed and published the first consensus statement on airway complications after lung transplantation. This consensus statement provides clear definitions of the common airway complications and also proposes a new adult and pediatric grading system based on the location and extent of ischemic injury, dehiscence and stenosis.

Advertisement

In addition to standardizing definitions and grading of complications, the intent of the consensus statement is to facilitate dialogue between pulmonologists and interventional bronchoscopy teams in developing standardized approaches to prevention and management of these complications.

With extensive experience in both lung transplantation and interventional pulmonology, Cleveland Clinic physicians and surgeons have been at the forefront of developing strategies to address airway complications. Our surgeons pioneered and investigated the impact of bronchial artery revascularization in reducing the risk of airway complications. Our interventional pulmonologists perform more than 250 procedures annually for airway complications after transplantation and also benefit from extensive experience in treating other benign and malignant airway disorders. This experience has allowed our team to introduce novel approaches, including use of uncovered metallic stents and amniotic membrane grafts in treating bronchial dehiscence after transplantation. Additionally, technical innovations, such as in vivo modification of stents and custom 3-D printed stents, developed by our team for airway complications in other patient populations now can be applied to management of post-transplant airway complications.

Airway

A patient suffered from severe refractory bronchial stenosis S/P B/L lung transplant. Stenosis involved RBI, RML and RLL superior segment. Multiple attempts were made to preserve segments.

Advertisement

Stent

Primary stent is placed and needle is used to poke hole in location or RML.

Balloon

Balloon dilation of newly created “airway” to RML

Stent

Stent in stent placement.

Adjustments

Minor adjustments made to stent allowing for ideal fit.

Result

Final result. In vivo stenting allowed for two additional years of airway patency with reduced procedures until patient unfortunately died in a motor vehicle accident almost eight years after transplant.

The combination of a successful, high-volume lung transplant program and an experienced interventional pulmonology team has positioned Cleveland Clinic to be a leader in the management of post-transplant airway complications. Through experience and innovation, we hope not only to develop effective treatment strategies but also techniques to mitigate the risk of developing these complications.

Dr. Budev is the Medical Director of Lung Transplantation and holds the Macon and Joan Brock Endowed Chair for Lung Transplantation.

Dr. Machuzak is staff in the Department of Pulmonary Medicine.

Advertisement

Related Articles

Patient doing yoga
November 13, 2026/Pulmonary/News & Insight

New Lung Wellness Clinic Offers a New Holistic Paradigm for Treating Patients With Chronic Lung Diseases and Breathlessness

Cleveland Clinic program combines traditional pulmonary care with integrative strategies to treat disease and improve breathing, movement and function

Headshot of Dr. Patel
November 6, 2026/Pulmonary/Podcast

Risk Assessment and Mitigation of Perioperative Pulmonary Complications (Podcast)

Patient factors, procedure and anesthesia strategy inform the risk of postoperative pulmonary complications

six panels of MRI scans of the heart
November 2, 2026/Pulmonary/News & Insight

Cardiac Sarcoidosis Demands Careful Screening and Coordinated Treatment

Overlapping symptoms and complex treatment decisions make care coordination essential

Pulmonary artery catheterization illustration
October 1, 2026/Pulmonary/News & Insight

Making the Most Out of Pulmonary Artery Catheterization

How careful measurement, provocative testing and repeat assessment can maximize the diagnostic value of PAC

Brian Southern, MD and Hetty Carraway, MD
September 10, 2026/Pulmonary/Podcast

Recognizing and Managing Telomere Biology Disorders (Podcast)

Cleveland Clinic experts discuss clinical clues, testing considerations and multidisciplinary care for patients with suspected short telomere syndromes

Thomas Fraser, MD
August 14, 2026/Pulmonary/News & Insight

Thomas Fraser, MD, on the Future of Infectious Disease Care

Cleveland Clinic’s new department chair discusses clinical priorities, prevention, stewardship and the evolving role of technology

Physician filling out survey

How the Sausage Is Made: The RVU Process in Modern Medicine

A look at how physician work is valued and why survey participation matters

Amy Attaway, MD, and Daniel Culver, MD
July 6, 2026/Pulmonary/Podcast

Relationship Between Intermittent Hypoxia, COPD and Comorbidities (Podcast)

A look at the emerging link between intermittent hypoxia and broader health effects in COPD

Ad